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Introduction
Aeromonads are recognized not only as an impor-
tant disease-causing pathogen of fish and other cold-
blooded organisms but also as a causative organism in 
a variety of infectious complications in both immuno-
competent and immunocompromised humans. The 
name Aeromonas is derived from Greek noun aeros 
(air, gas) and monas (unit). Members of the genus Aero­
monas can be referred to as aeromonad. Aeromonads 
(Phylum Proteobacteria, Class Gammaproteobacteria, 
Order Aeromonadales, Family Aeromonadaceae) are 
Gram-negative, non-spore forming, rod shaped, fac-
ultative anaerobic bacteria that occur in natural water 
bodies of the environment. They are similar in many 
characters to Enterobacteriaceae family.
The DNA-DNA hybridization studies showed the 
presence of 33 DNA hybridization groups, includ-
ing 19 genospecies. Aeromonas hydrophila, A. caviae, 
A. sobria, A. veronii, and A. schubertii are mesophilic, 
whereas, A. salmonicida are non-motile and psy- 
chrophilic. Widely distributed, aeromonads have been 
isolated from various sources like freshwater fishes, 
drinking water supply, environmental samples, pol-
luted waters, food items like meat, fish, milk, ready 
to eat items and oysters (Abeyta et al., 1986; Altwegg 
et al., 1990; Manna et al., 2013, Figueras et al., 2017). 
Aeromonas have been found in the Aedes aegyptii and 
Culex quinque fasciatus mosquitoes’ midgut, in monkey 
faeces and bivalve molluscs (Pidiyar et al., 2002), larvae 
of Chironomus plumosus (Rouf and Rigney, 1993).
Over the past few years, researchers have renewed 
interest in the genus Aeromonas as an emergent human 
pathogen (Janda and Abbott, 1998). Aeromonads have 
been implicated in septicaemia in variety of aquatic 
organisms and gastrointestinal/extra-intestinal disea-
ses in humans (Janda and Duffey, 1988; Janda and 
Abbott, 1996). Several species of genus Aeromonas 
have been implicated in pathogenic cases in human, 
like cellulitis, surgical wound infections, nosocomial 
pneumonia, hemolytic-uremic syndrome, sepsis, peri-
tonitis, meningitis, urinary tract infections, and severe 
muscle degeneration. In all the cases it seems that Aero­
monas-mediated pathogenesis occurs both in cases of 
Bacteriological, Clinical and Virulence Aspects
of Aeromonas-associated Diseases in Humans
UTTARA DEY BHOWMICK and SOUMEN BHATTACHARJEE*
Cell and Molecular Biology Laboratory, Department of Zoology, University of North Bengal,
Raja Rammohunpur, Siliguri, District Darjeeling, West Bengal, India
Submitted 13 January 2017, revised 29 December 2017, accepted 23 January 2018
A b s t r a c t
Aeromonads have been isolated from varied environmental sources such as polluted and drinking water, as well as from tissues and body 
fluids of cold and warm-blooded animals. A phenotypically and genotypically heterogenous bacteria, aeromonads can be successfully 
identified by ribotyping and/or by analysing gyrB gene sequence, apart from classical biochemical characterization. Aeromonads are 
known to cause scepticemia in aquatic organisms, gastroenteritis and extraintestinal diseases such as scepticemia, skin, eye, wound and 
respiratory tract infections in humans. Several virulence and antibiotic resistance genes have been identified and isolated from this group, 
which if present in their mobile genetic elements, may be horizontally transferred to other naive environmental bacteria posing threat to the 
society. The extensive and indiscriminate use of antibiotics has given rise to many resistant varieties of bacteria. Multidrug resistance genes, 
such as NDM1, have been identified in this group of bacteria which is of serious health concern. Therefore, it is important to understand 
how antibiotic resistance develops and spreads in order to undertake preventive measures. It is also necessary to search and map putative 
virulence genes of Aeromonas for fighting the diseases caused by them. This review encompasses current knowledge of bacteriological, 
environmental, clinical and virulence aspects of the Aeromonas group and related diseases in humans and other animals of human concern.
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immunosuppression and immunocompetence (Wang 
et al., 2003). However, Aeromonas-mediated mecha-
nism of pathogenesis in both aquatic organisms and in 
human subjects remains to be elucidated.
Aeromonas spp. possess multifactorial virulence 
genes and systems. Several groups have demonstrated 
the presence of aerolysin (Chakraborty et al., 1986), 
hemolysin (Wang et al., 1996), extracellular lipase 
(Anguita et al., 1993), cytolytic enterotoxin (Chopra 
et al., 1993), haemolytic toxin genes (Khan et al., 1998), 
acetylcholinesterase (Nieto et al., 1991) and proteases 
(Leung and Stevenson, 1988). Genome level scans have 
identified virulence factors in potential open reading 
frames (ORFs) and few putative genes, like O-antigen 
and capsule, gene cluster in phage and type III secretion 
system have been associated with virulent aeromonads. 
Several genomic islands (GIs) with unusual G-C con-
tent, have also been identified that carry mobility-asso-
ciated genes, such as integrases or transposes and other 
putative virulence genes (Yu et al., 2005). Aeromonas 
luxRI quorum sensing gene homologs and Ribonucle-
ase R (Vac B) have also been implicated in modulation 
and expression of these virulence genes (Jangid et al., 
2007; Erova et al., 2008). The NDM-1 gene (blaNDM-1) 
has been found in aeromonads of North India (New 
Delhi) (Walsh et al., 2011).
Aeromonads are found to inhabit a variety of niches 
including soil, aquatic habitats, aquatic animals, terres-
trial animals, birds, insects, and human beings (Table I). 
A. hydrophila are found to inhabit a wide range of ther-
mal and pH conditions, except in extremely polluted 
and saline water and hot water springs. Estuaries are 
ideal for Aeromonas, where they either exist freely or 
associated with crustaceans (Fiorentini et al., 1998). 
Most of the aeromonads come into human systems 
through ingestion of water or food contaminated 
with Aeromonas. In India, Aeromonas spp. have been 
detected in 13.4% of animal-origin food samples, the 
highest being in fish (Kumar et al., 2000). Aeomonads 
mostly infect the gastrointestinal tract, urinary tract 
and blood of human beings. Three Aeromonas species 
viz., A. hydrophila, A. caviae and A. veronii bv. Sobria 
are known to infect human beings (Janda and Abbott, 
1998). Some other species like A. jandaei, A. veronii bv. 
veronii, A. schubertii, A. popoffi are also known to infect 
human (Janda et al., 1994; Hua et al., 2004). Hua et al. 
(2004) isolated A. popoffi from the urine of a patient 
with urinary tract infection (Hua et al., 2004). A. salmo­ 
nicida, generally known to infect cold blooded animals, 
has also been isolated from blood sample of a patient 
in India (Tewari et al., 2014). A. salmonicida was identi-
fied by Vitek 2 compact automated system. Non-cul-
turable Aeromonas can be found in drinking water in 
various concentrations. The first report of Aeromonas 
from drinking water was confirmed by sequencing 16S 
rRNA (Figueras et al., 2005). Different concentrations 
of Aeromonas have been detected in consumable prod-
ucts from markets (Isonhood and Drake, 2002).
Epidemiology
Mesophilic bacteria grow well at higher tempera-
tures and therefore an increase in bacterial load may 
be attributed to their increase in concentration in both 
freshwater environments and drinking water sources 
with the increase of ambient temperature (Moyer, 1987; 
Edberg et al., 2007; Khardori and Fainstein, 1988). The 
seasonality is also seen in extra-intestinal infections 
such as septicemia, where 42% to 67% of bacteremic 
diseases appear during the summer season (Tsai et al., 
2006). The elevated levels of these bacteria in aquatic 
environments during the summer season increases the 
opportunities of human or aquatic organisms of getting 
exposed to them and thus the risk of getting infected 
by these bacteria also gets higher. Infections caused by 
aeromonads seem to be rather more prevalent in devel-
oping countries like India, Bangladesh, Brazil, China, 
Cuba, Egypt, Iran, Libya, Nigeria, Venezuala and Viet-
nam (Ghenghesh et al., 2008). Prevalence of Aeromonas 
related disease is more during rainy seasons when the 
water salinity is low than at high salinity during dry 
season (Marcel et al., 2002).
Infections and Symptoms
Gastrointestinal tract is the most common site of 
Aeromonas infection. Evidences show that Aeromonas-
associated diarrhoea or cholera-like disease occurs 
in some patients, whereas no symptom may appear 
in cases of low-level infections (Gurwith et al., 1977; 
Holmberg et al., 1984). Kelly et al. (1993) isolated 
Aeromonas from non-fecal samples from 58 patients, 
suffering from gangrene, septicemia, osteomyelitis 
and peritonitis. Aeromonas-related diarrhoea may be 
watery and self-limiting. In other cases, fever, abdomi-
nal pain and bloody diarrhea may develop along with 
dehydration (Ghenghesh et al., 1999). Hematologic 
cancer patients, patients with tumours in their gastro-
intestinal tract or having alimentary canal diseases are 
more likely to be infected by Aeromonas. In rare cases 
of segmental colitis Aeromonas segmental colitis may 
occur that seem to be ischemic colitis or Crohn’s disease 
(Bayerdorffer et al., 1986). Although any portion of the 
colon may be affected, it mostly affects the ascending 
or transverse sections. Iileal ulceration has also been 
linked to Aeromonas enteritis (Yamamoto et al., 2004). 
It may also cause intra-mural intestinal hemorrhage 
including small bowel obstruction (Block et al., 1994), 
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 1 ATCC 7966 A. hydrophila A. hydrophila Isolated from clinical specimens Martin-Carnahan
     and Joseph, 2005
 1 BCCM/LMG 19562 A. hydrophila subsp. A. hydrophila subsp. Isolated from clinical specimens Martin-Carnahan
  dhakensis dhakensis  and Joseph, 2005
 1 BCCM/LMG 19707 A. hydrophila subsp. A. hydrophila subsp. ranae Pathogenic for frogs Martin-Carnahan
  ranae   and Joseph, 2005
 2 ATCC 14715 A.bestiarum A. hydrophila­ like Isolated from clinical specimens Martin-Carnahan
     and Joseph, 2005
 3 ATCC 33658 A. salmonicida A. salmonicida subsp. Nonmotile fish pathogen Martin-Carnahan
   Salmonicida  and Joseph, 2005
 3 ATCC 33659 A. salmonicida A. salmonicida subsp. Nonmotile fish pathogen Martin-Carnahan
   Achromogenes   and Joseph, 2005
 3 ATCC 27013 A. salmonicida A. salmonicida subsp. Nonmotile fish pathogen Martin-Carnahan
   Masoucida  and Joseph, 2005
 3 ATCC 49393 A. salmonicida A. salmonicida subsp. Nonmotile fish pathogen Martin-Carnahan
   Smithia  and Joseph, 2005
 3 CDC 0434-84, Unnamed A. hydrophila- like Isolated from clinical specimens Martin-Carnahan
 Popoff C316    and Joseph, 2005
 4 ATCC 15468 A. caviae A. caviae Isolated from clinical specimens Martin-Carnahan
     and Joseph, 2005
 5A CDC 0862-83 A. media A. caviae-like Isolated from clinical specimens Martin-Carnahan
     and Joseph, 2005
 5B CDC 0435-84 A. media A. media  – Martin-Carnahan
     and Joseph, 2005
 6 ATCC 23309 A. eucrenophila A. eucrenophila  – Martin-Carnahan
     and Joseph, 2005
 7 CIP 7433, A. sobria A. sobria  – Martin-Carnahan
 NCMB 12065    and Joseph, 2005
 8X CDC 0437-84 A. veronii A. sobria  – Martin-Carnahan
     and Joseph, 2005
 8Y ATCC 9071 A. veronii A. veronii biovar sobria Isolated from clinical specimens Martin-Carnahan
     and Joseph, 2005
 9 ATCC 49568 A. jandaei A. jandaei Isolated from clinical specimens Martin-Carnahan
     and Joseph, 2005
10 ATCC 35624 A. veronii biovar A. veronii biovar veronii Isolated from clinical specimens Martin-Carnahan
  veronii   and Joseph, 2005
11 ATCC 35941 Unnamed Aeromonas spp. (ornithine  – Martin-Carnahan
   Positive  and Joseph, 2005
12 ATCC 43700 A. schubertii A. schubertii Isolated from clinical specimens Martin-Carnahan
     and Joseph, 2005
13 ATCC 43946 Aeromonas A. schubertii-like Isolated from clinical specimens Martin-Carnahan
  Group 501   and Joseph, 2005
14 ATCC 49657 A. trota A. trota Isolated from clinical specimens Martin-Carnahan
     and Joseph, 2005
15 ATCC 51208, A. allosaccharophila A. allosaccharophila  – Martin-Carnahan
 CECT 4199    and Joseph, 2005
16 ATCC 51020 A. encheleia A. encheleia Pathogenic for eels Martin-Carnahan
     and Joseph, 2005
17 BCCM/LMG A. popoffii A. popoffii  – Martin-Carnahan
 1754    and Joseph, 2005
UA MTCC 3249, A. culicicola A. culicicola Isolated from mosquitoes Martin-Carnahan
 NCIM 5147    and Joseph, 2005
Table I
Genomospecies and phenospecies of the genus Aeromonas.
DNA
Hybri-
dization
group
Type Strain/
Reference Genospecies Phenospecies Remarks Reference
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and refractory inflammatory bowel disease (Doman 
et al., 1989). Gastrointestinal tract infection symptoms 
may mimic cholera (Mohan et al., 2017).
The second most common area of Aeromonas­
related infection in our body is the skin and the soft 
tissues underlying the skin. Aeromonads may cause 
several types of skin and soft tissue infections, ranging 
from mild problems like pustular lesions to dangerous 
conditions that can cause morbidity in infected person. 
Some of these conditions include cellulitis, necrotizing 
fasciitis, myonecrosis, septic arthritis and septic shock 
(Lai et al., 2007). Some medical treatment procedures 
like medicinal leech therapy, appendectomies, colec-
tomy, cholecystectomy and elective surgery enhance 
UA-Unassigned;  – Un Named
UA  – A. eucrenophila A. tecta Isolated from clinical and Demarta et al.,
    environmental sources 2008
UA  – A. trota A. aquariorum Isolated from monkey faeces Harf-Monteil
     et al., 2004
UA  – A. popoffii A. bivalvium Isolated from aquaria Martinez-Murcia
    of ornamental fish et al., 2008
UA  – Unnamed A. sharmana Isolated from bivalve molluscs Minana-Galbis
     et al., 2004
UA 868ET (= CECT 7113T A. bivalvium sp. nov.  – Isolated from bivalve molluscs Minana-Galbis
 = LMG 23376T)    et al., 2007
UA  – A. schubertii A. simiae Isolated from midgut Pidiyar et al.,
    of Mosquitoes 2002
UA  – A. sharmana sp. nov. A. sobria Isolated from a warm spring Saha and
     Chakrabarti, 2006
UA 266T (5CECT 8023T Aeromonas Aeromonas fluvialis, Isolated from irrigation water Aravena-Roman
 5LMG 26707T) australiensis sp. nov. Aeromonas veronii and system et al., 2013
   Aeromonas allosaccharophila
UA A.11/6T Aeromonas lusitana  – Isolated frm untreated water Martinez-Murcia
 (= DSMZ 24095T, sp. nov.  and vegetables (lettuce/celery) et al., 2016
 = CECT 7828T)
UA ATCC 49803 Aeromonas Aeromonas trota Isolated from human stool Schubert et al., 
  enteropelogenes   1990
UA CECT 4254T Aeromonas diversa Aeromonas schubertii Isolated from leg wound Farfan et al., 2013
    of a patient
UA 717T (= CECT 7401T Aeromonas fluvialis Aeromonas veronii Isolated from river water Alperi et al., 
 = LMG 24681T)    2010b
UA 848TT (= CECT 5864T  Aeromonas  – Isolated from Wedge-shells Minana-Galbis 
 = LMG 22214T) molluscorum sp. nov.   et al., 2004
UA WB4.1-19T  Aeromonas rivuli  – Isolated from a karst hard Figueras et al.,
 (CECT 7518T sp. nov.  water creek 2011
 DSM 22539T
 MDC 2511T) 
UA S1.2T (= CECT 7443T Aeromonas piscicola  – Isolated from wild diseased Beaz-Hidalgo
 = LMG 24783T) sp. nov.  Salmon et al., 2009
UA A2-50T Aeromonas  – Isolated from wound Alperi et al.,
 (= CECT 7403T taiwanensis sp. nov.  infection of a patient 2010a
 = LMG 24683T)
UA A2-67T Aeromonas  – Isolated from a wound culture Alperi and
 (= CECT 7402T sanarellii sp. nov.  from a patient Figueras, 2010
 = LMG 24682T)
UA  A. hydrophila  – Isolated from wild birds Glunder and
     Seigmann, 1989
Table I. Continued.
DNA
Hybri-
dization
group
Type Strain/
Reference Genospecies Phenospecies Remarks Reference
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the chances of Aeromonas-associated wound infec-
tions (Moawad and Zelderman, 2002; Tena et al., 2009). 
A. hydrophila and A. caviae were isolated from five burn 
patients admitted in Royal Brisbane hospital, where the 
patients had been immersed in water immediately after 
getting burnt, putatively contaminated with Aeromonas 
(Kienzle et al., 2000).
A. hydroplila sensu stricto, A. caviae and A. veronii 
bv. Sobria have been implicated in blood borne infec-
tions. Less frequently, three other species namely, 
A. jandaei, A. veronii bv. veronii and A. schubertii are 
known to cause sepsis (Janda et al., 1994). Aeromonas-
septicemia is more prevalent in immunocompromised 
conditions viz. myeloproliferative disorders, chronic 
liver disease, neoplasia, biliary disease, AML, myelo-
plastic syndromes, non-Hodgkin’s lymphoma and acute 
lymphocytic leukemia (Ko et al., 2000; Tsai et al., 2006). 
Aeromonas septicemia is also related to diseases like 
diabetes mellitus, renal and cardiac problems, thalla-
semia, multiple myeloma, aplastic anemia and Wal-
denstrom’s macroglobulinemia (Janda and Abbott, 
1996; Padmaja et al., 2013). Aeromonad-contaminated 
catheters and dialysis chambers may serve as points of 
entry into human blood. Aeromonas cause peritonitis 
and cholangitis as intra-abdominal disease. Aeromonas-
associated cholangitis may result in pancreatic carci-
noma, cholangiocarcinoma, cholelithiasis patients or 
patients with non-malignant biliary disease by the inva-
sion of the bacteria from the gastrointestinal tract to 
the biliary tract via surgery or endoscopy (Chan et al., 
2000). A. hydrophila, A. veronii bv. Sobria, A. popoffi 
and A. caviae infections have been implicated in UTI, 
aspiration pneumonia, keratitis, endophthalmitis, cor-
neal ulceration and blood stream infections through 
biofilm formation (Ender et al., 1996; Hsueh et al., 1998; 
Miyake et al., 2000; Hua et al., 2004; Pinna et al., 2004; 
Hondur et al., 2008; Tang et al., 2014). First case of neo-
natal meningitis in a premature baby has been reported 
recently caused by A. hydrophila (Kali et al., 2016).
Aeromonas affects both cold and warm-blooded 
non-human animals. Mass deaths in fishes occur every 
year due to Aeromonas-associated diseases resulting in 
huge economic loss to the fish industry (Monette et al., 
2006). Furunculosis in the salmonids, caused by A. sal­
monicida sensu stricto is characterized by symptoms like 
heamorrhages at fin bases, muscles and internal organs; 
loss of appetite, disordered melanin production, loss of 
energy and exopthalmia (Austin, 1997). Secondly, sep-
ticemia in carps, tilapia, catfishes, salmons, cods, bass 
and freshwater prawns is caused by A. hydrophila and 
A. veronii (Joseph and Carnahan, 1994). A. hydrophila 
has been detected in tissues like kidney, liver and blood 
of carps in farms (Mohanty et al., 2008). Incidences of 
A. hydrophila seem to be more prevalent than A. cav­
iae and A. sobria, which indicates that A. hydrophila, is 
more virulent than the other (Daood, 2012). In a very 
recent study it was shown that A. caviae infection causes 
thrombocytopenia which contributes to elongation of 
clotting time which leads to hamorrhages in internal 
organs, muscles and bases of fins (Baldissera et al., 
2018). Diseases in other ectothermic animals include 
ulcers (Lizards and snakes), “red leg” disease (frogs), 
septicemia (dogs), septic arthritis (calves), vesiculitis 
(bulls) (Gosling, 1996).
Pathogenicity
The identified virulence factors in Aeromonas are 
haemolysins, cytotoxins, enterotoxins, proteases [ser-
ine protease (AspA), elastase (AhpB)], lipases (Pla and 
Plc, Sat), DNAses, adhesins [type IV pili, polar flagella 
(FlaA and FlaB)] (Agarwal et al., 1998; Cascon et al., 
2000; Rabaan et al., 2001), capsule and T3SS (Grim 
et al., 2013). Genome sequencing and annotation can 
be used to detect these virulence factors in Aeromonas 
(Grim et al., 2013). Enterotoxins, Act and Ast (Sha et al., 
2002), elastase (Cascon et al., 2000), flagellin (Rabaan 
et al., 2001), and Stx1 and Stx2 (Alperi and Figueras, 
2010) are directly involved in the pathogenesis. In 
a study Aeromonas isolates from well, tap and bottled 
water samples were found to have aer and ast genes, 
which poses a serious health concern for the human 
society (Didugu et al., 2015).
Aeromonas inections are mostly polymicrobial 
(Figueras and Beaz-Hidalgo, 2015), in which there is 
competition and cooperation between the bacterial cells 
(Armbruster et al., 2016). Virulence when checked in 
C. elegans was found to be higher in paired Aeromonas 
infections than in single strain (Mosser et al., 2015). 
The dual strain A. hydrophila infection showed syn-
ergistic effect by local tissue damage and antagonistic 
effect by elimination (Ponnusamy et al., 2016). The 
pathogenic potential of A. veronii isolates from clinical 
samples when tested were found to be like the drink-
ing water and environmental isolates (Lye, 2011). The 
protein secretion systems of Aeromonas play impor-
tant roles in pathogenesis caused by them. The type II 
secretion system is associated with the extracellular 
release of proteases, amylases, DNases and aerolysin 
(Pang et al., 2015). Type III secretion system, which is 
found in greater frequency in clinical isolates than envi-
ronmental ones (Pang et al., 2015) functions by insert-
ing effective toxins inside the host cells (Sierra et al., 
2010). The type VI secretion system allows insertion of 
virulence factors into host cells through valine-glycine 
repeat protein and hemolysin-coregulated proteins. 
These proteins when secreted show antimicrobial pore-
forming properties or remain as structural proteins 
(Bingle et al., 2008).
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Gastroenteritis. Aeromonads enter the human gut 
via oral cavity, escape the effects of gastric acidity and 
produce bacteriocin-like compounds, which facilitate 
colonization of the intestine. They attach themselves to 
gastrointestinal epithelium, form biofilm, colonize and 
elaborate virulence factors to cause infection. Bacterial 
flagella and pili play important roles in gastric patho-
genicity (Kirov et al., 2000). 
Wound infections. Virulence caused by Aeromonas 
and the virulence factors possessed by them are similar 
to those of Gram-negative P. aeruginosa. The first step is 
settlement of the bacteria in wound site with the help of 
adhesion factors such as OmpA protein (Namba et al., 
2008). The second step involves production of proteases 
(metalloproteases, serine proteases and aminopepti-
dases) and the breakdown of proteinaceous material 
of the host cells to gain energy, for multiplication of 
bacilli (Janda, 2001). The third step includes the entry 
of aeromonads into deeper tissues via chemotactic 
motility (Janda, 1985).
Septicemia. Most cases of primary Aeromonas sep-
ticaemia apparently arise through transfer of bacteria 
from the gastrointestinal tract into the blood circulatory 
system. They may also travel to the bloodstream from 
infected wounds, peritonitis, or biliary disease. Most 
of the Aeromonas septicemias are caused by a  small 
number of species. Specific strains having certain mark-
ers are only responsible for most of the blood-borne 
diseases. Aeromonads of sergroups O:11, O:16, O:18, 
and O:34 are responsible for most cases of septicemia, 
which shows that lipo-polysaccharide (LPS) antigens 
are important in causing systemic diseases. The pres-
ence of LPS or the S layers makes most Aeromonas iso-
lates resistant to the lytic effects of the host’s classical 
complement pathway (Janda et al., 1994). 
Genes involved in virulence
Cytotoxic enterotoxin (act), haemolysin (hlyA)/ 
aerolysin (aerA). The act gene of A. hydrophila encodes 
cytotoxic enterotoxin, which has many functions 
viz., cytotoxic, haemolytic and enterotoxic activities 
(Chopra and Houston, 1999). Other aeromonads have 
haemolytic activities due to the presence of other genes, 
namely hlyA and aerA, and these strains may have one 
or more of these genes (Heuzenroeder et al., 1999). The 
mature aerolysin binds to host cells, aggregates there 
and forms holes in their cell membrane destroying the 
permeability barrier of the membrane, which ultimately 
leads to osmotic lysis of the cells (Howard and Buckley, 
1982). The haemolysin induces accumulation of fluids 
in intestinal loops (Asao et al., 1986), release of certain 
inflammation promoting factors from the granulocytes 
(Scheffer et al., 1988) and apoptosis of the host cells 
(Nelson et al., 1999). A study showed that about 50% of 
the marine fish samples were positive for the haemoly-
sin gene hyl in India (Reshma et al., 2015). In another 
study, both environmental and clinical isolates from 
Kolkata (erstwhile Calcutta) in India were found to 
be positive for act and the enteropathogenic poten- 
tial of these isolates were found to be comparable to 
V. cholerae (Bhowmik et al., 2009). 
Cytotonic enterotoxins (ast, alt). The cytotonic 
enterotoxins do not degenerate the small intestine. The 
clones of E. coli having cytotonic enterotoxin genes have 
been showed to cause elongation of Chinese hamster 
ovary (CHO) cells, which also produces cyclic AMP, 
and these are enterotoxic responses. The Alt enterotoxin 
is heat labile, whereas Ast is heat stable at 56°C (Chopra 
and Houston, 1999). These genes have strong roles in 
causing diarrhoea (Sha et al., 2002).
Elastase (ahpB). The knocking out of the ahpB gene 
in A. hydrophila causes a high rise in the LD50 value 
of A. hydrophila in fishes, which indicates that elas- 
tase, a zinc metalloprotease, is an important virulence 
factor to cause disease in organisms (Cascon et al., 
2000). The ahpB gene in A. hydrophila encodes pro- 
tease with both elastolytic and caseinolytic activities 
(Cascon et al., 2000).
Flagella. Most of the Aeromonas species and all of 
the species responsible for human pathogenesis are 
motile having polar flagella. The polar flagellum has 
five flagellin subunits Fla A, Fla B, Fla G, Fla H and 
Fla  J. The flaA and flaB genes have been cloned and 
sequenced from A. salmonicida (Umelo and Trust, 
1997). All the five genes (flaA, flaB, flaG, flaH and flaJ) 
were identified in polar flagellin locus of A. caviae. 
Motility is known as an important virulence factor in 
the aeromonads. Mutation in either flaA or flaB did not 
affect development of flagellum but did reduce adher-
ence and motility by approximately 50%. Mutations 
in flaH, flaJ or both cause complete loss of motility, 
development of flagellum and ability to get attached to 
HEp-2 cells. Thus, the ability to get attached to Hep-2 
cells depends on motility and presence of flagella of 
aeromonads (Rabaan et al., 2001). 
Lipase. Lipases change the plasma membrane of the 
host, increasing the severity of disease (Nawaz et al., 
2010). Lipase gene has been recovered from multidrug-
resistant virulent aeromonads capable of forming bio-
films isolated from cattle feaces (Igbinosa et al., 2015).
Shiga toxins (Stx1 and Stx2). Shiga toxins are pro-
tein toxins, which have two parts A and B. One part has 
enzymatic property and the other binds to the surface 
of the host cells. These toxins inhibit protein synthesis 
of the host cells (Sandvig, 2001) and also induce apop-
tosis (Jones et al., 2000).
Enolase. Enolase is a glycolytic enzyme expressed 
in cell surfaces, which binds to human plasminogen 
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leading to the production of plasmin which degrade 
plasma proteins. Enolase is also a heat-shock protein, 
which regulated transcription and is also necessary for 
cell viability (Sha et al., 2009). 
Others. Other virulence factors include adhesins 
(Huang et al., 2015), nucleases (Ji et al., 2015), pore 
forming toxins (Saurez et al., 2012) and catalysts.
Antimicrobial Susceptibility
All species of Aeromonas show similar antibiotic 
susceptibility profiles, which are also independent of the 
origin of the isolates (Kampfer et al., 1999). Most of the 
aeromonads have inducible chromosomal lactamases, 
which are their main resistance mechanisms. Among 
these, metallo-β-lactamases, which work against car-
bapenems, are of major concern (Janda, 2001; Zhiyong 
et al., 2002). The Clinical and Laboratory Standards 
Institute (CLSI) have published consensus guideline for 
testing Aeromonas (Jorgensen and Hindler, 2007). The 
susceptibility status of Aeromonas isolates for therapeu-
tically active drugs also seem to be species independent 
with one exception of Aeromonas trota, which is sus-
ceptible to ampicillin (Carnahan et al., 1991). In a study 
antibiotic resistance status of Aeromonas isolates from 
diseased fishes were found to be similar to those iso-
lated from the freshwater fish farm (Daood, 2012). In 
another study Aeromonas strains resistant to mercury 
and arsenite were found and these got transferred to 
E. coli when conjugation experiments were performed 
(Huddleston et al., 2006).
Resistance Mechanisms. Three major classes 
of β-lactamases are present in Aeromonas species, 
viz, C  cephalosporinase, D penicillinase, and a  class 
B  metallo-β-lactamase (MBL) (Libisch et al., 2008). 
Fosse et al. (2003) classified strains expressing these 
β-lactamases into five groups as A. hydrophila: class 
B, C, and D β-lactamases, A. caviae: class C and 
D β-lactamases, A. veronii: class B and D lactamases, 
A. schubertii: class D  lactamases and A. trota: class 
C β-lactamases. Many A. veronii bv. Sobria isolates also 
express a class C cephalosporinase. In few cases, infect-
ing Aeromonas strains expressed a class A β-lactamase 
of the TEM family of ESBLs (Extended Spectrum 
β-Lactamases), a character similar to the Enterobacte­
riaceae (Marchandin et al., 2003). The β-lactamases are 
involved in detoxification of antibiotics, changes in the 
drug binding site of the target and inhibiting the entry 
of the drug into the bacterial cells by causing changes 
in structure and function of the cytoplasmic and cell 
membranes (Benveniste and Davies, 1973). Each strain 
can produce a maximum of three β-lactamases, which 
work in a coordinated manner (Walsh et al., 1997). Class 
C cephalosporinases of the AmpC family are resistant 
to cephamycins, extended spectrum cephalosporins 
and β-lactamase inhibitor compounds, like clavulanic 
acid, tazobactam, and sulbactam, which hydrolyse the 
CO-NH bond in the lactum ring of cephalosporin to 
inactivate it (Fosse et al., 2003).
“CphA”, is the most common MBL produced by Aero­ 
 monas species, which is largely found in A. hydrophila 
and A. veronii isolates (Walsh et al., 1997). Two other 
MBLs (VIM and IMP) are also found in A. hydrophila 
and A. caviae strains, which encode an integron and 
a  plasmid, respectively (Libisch et al., 2008). These 
MBL-producing strains are resistant to ceftazidime, 
cefepime, imipenem, and piperacillin-tazobactam; both 
strains are found to be susceptible to aztreonam in vitro. 
MBLs work in a two-step process: firstly, the C-N bond 
of the beta-lactam antibiotic is cleaved and then the 
binding nitrogen is protonated (Crowder et al., 2006).
Recently, NDM-1 (blaNDM-1) gene has been detected 
in this group of bacteria (Walsh et al., 2011). The spread 
of mobile NDM-1, also known as carbapenemase, is of 
great concern, not only because these enzymes confer 
resistance to carbapenems and other β-lactam anti-
biotics, but also because such pathogens typically are 
resistant to multiple antibiotic classes, making treat-
ment difficult. Plasmids having the sequence encoding 
this carbapenemase can have up to 14 other antibiotic-
resistance determinants and can make other bacte-
ria also resistant, resulting in multi-drug resistant or 
extreme drug-resistant phenotypes. Resistance of this 
scale could have serious public health implications 
because modern medicine is dependent on the ability 
to treat infection (Livermore, 2009). 
Quinolone resistance in Aeromonas strains isolated 
from two European rivers is a matter of rising concern 
because quinolone was previously known to be effec-
tive in combating Aeromonas infections (Goni-Urriza 
et al., 2000). Several A. caviae strains showed resistance 
to nalidixic acid, ciprofloxacin, and norfloxacin (Sinha 
et al., 2004). Aeromonads pathogenic to fish are found 
to be resistant to amoxicillin, ampicillin-sulbactum and 
streptomycin (Abu-Elala et al., 2015). These antibiotic 
resistant bacteria come into the environment through 
improper septic systems, agriculture and wastewater 
treatment plants (Rosenblatt-Farrell, 2009). River sedi-
ments adsorb antibiotics (Zhou et al., 2011) some of 
which may remain there for months (Lai et al., 2011). 
These impart antibiotic resistance to bacterial popula-
tions at that location. Biofilm formation increases resist-
ance to antimicrobial substances (Acker et al., 2014), 
disinfectants (Jahid and Ha, 2014). Biofilm formation 
in Aeromonas is affected differently in different strains 
under several food related stresses. However, low tem-
perature and pH conditions were found to facilitate bio-
film formation in a recent study, which is the first study 
of this kind regarding Aeromonas (Nagar et al., 2017).
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Role of plamids, integron systems and transposons
in disease transmission
In Aeromonas, gene transfer mainly occurs through 
conjugation and transformation, in which type IV pili 
play a vital role (Huddleston et al., 2013). In a study, 
seven ESBL and two AmpCBL-producing Aeromonas 
strains were able to transfer their antibiotic resistance 
genes to E. coli (Bhaskar et al., 2015). Bacterial conju-
gative plasmids, transposable elements and integron 
systems are the panoply on which bacteria depend for 
their resistance to anti-bacterial compounds. Plasmids 
in particular serve as a platform on which useful resist-
ance genes are assembled and subsequently dissemi-
nated (Bennett, 2008). Plasmid profiling and molecular 
characterization of aeromonad plasmids were under-
taken by several research groups to address to the 
problems of generation and transmission of antibiotic 
resistance genes (Toranzo et al., 1983; Rhodes et al., 
2000). Studies in eastern India focussed on the char-
acterization of Aeromonas spp. isolated from cyprinid 
and silurid fishes affected with ulcerative disease (EUS) 
and the involvement of a low molecular weight plasmid 
has been implicated in the etiology of this disease in 
fishes (Pradhan and Pal, 1990; Majumdar et al., 2006; 
Majumdar et al., 2007). Subsequent investigations have 
also proved that, the degree of antibiotic resistance in 
these bacterial isolates is gradually increasing through 
the years (Pradhan and Pal, 1993; Saha and Pal, 2002; 
Das et al., 2009; Pal and Bhattacharjee, 2011).
Our laboratory tested antibiotic resistance status in 
few environmental Aeromonas isolates and the results 
showed an increase in antibiotic resistance in case of 
some antibiotics, while decrease in resistance in others 
(Dey Bhowmick and Bhattacharjee, 2017). Since anti- 
biotic resistance is increasing in Aeromonas, aquacul-
ture should resort to alternate means such as probiotics, 
essential oils and phage therapy to combat this problem.
In contrast to bacterial conjugative plasmids, which 
tend to be larger, mobilizable resistance plasmids tend 
to be relatively smaller (~10 to 20 kb) and encode only 
a  handful of genes including the resistance gene(s) 
(Bennet, 2008). Therefore, resistance to multi-drugs 
and presence of small-sized plasmids in environmental 
isolates of this medically important bacteria group may 
indicate potential threat to human and culture fisher-
ies (Pal and Bhattacharjee, 2011). Through horizontal 
gene transfer R-plasmids are spread between different 
species of Aeromonas, which spread multi-drug resist-
ance (Indra et al., 2015). Transfer of antibiotic resist-
ance genes from Aeromonas to other environmental 
and clinical bacteria makes treatment of both fish and 
humans difficult. Presence of multidrug resistance 
genes on mobile genetic elements is therefore a serious 
threat to society (Piotrowska and Popowska, 2015).
Conclusion
Phenotypically and genotypically a heterogenous 
group, aeromonads have been detected, isolated and 
characterized from varied sources such as brackish, 
fresh, estuarine, marine waters, chlorinated and un-
chlorinated water supplies, heavily polluted waters, cold 
and warm-blooded animals and humans alike. In con-
trast to the traditional morphological and biochemi-
cal differentiation, identification of aeromonads from 
clinical and environmental sources are presently based 
on PCR-based genotyping approach such as ribotyping 
and analysis of gyrB. 
In the post World War II period, extensive use (or 
abuse) of antibiotics have given rise to drug-resistant 
varieties of bacteria, owing to the success and speed 
of bacterial adaptation. Bacteria apply many mecha-
nisms to show antibiotic resistance. These resistance 
genes get accumulated in plasmids and are thought to 
spread among other bacteria through them. In order 
to find solution to this problem many researchers have 
undertaken plasmid profiling and molecular charac-
terization of aeromonad plasmids (Toranzo et al., 1983). 
Therefore, assessment of anti-microbial drug resistance 
and possible involvement of bacterial plasmids in this 
resistance, in the locally isolated clinically and agricul-
turally important aeromonads, may be rewarding. To 
understand fully the virulence potential of any patho-
gen, it is imperative to understand pathogenic factors 
and/or mechanisms that are involved in their virulence. 
This is crucial since the expression of different virulence 
genes could contribute to infection depending upon 
the anatomical niche where the pathogenic organisms 
colonize and the microenvironment that dictates the 
differential expression of genes.
So far, many virulence factors have been discovered 
and characterized from Aeromonas group, especially 
from A. hydrophila, the causative organism of septice-
mia, wound infections and diarrhoea in humans and 
in animals. Novel putative virulence factors and/or 
virulence transfer systems, such as the NDM-1 gene, 
are being discovered on a regular basis in this diverse 
and ubiquitous group of bacteria. Although its emer-
gence and distribution is controversial, the detection of 
NDM-1 gene in this clinically and agriculturally impor-
tant bacteria group calls for a detailed surveillance of 
antibiotic resistance and also mode of transferability of 
NDM-1 gene in this bacteria group.
Plasmid-mediated horizontal gene transfer and 
acquisitions are thought to be one of the many adaptive 
ways by which bacteria acquire genes that may be useful 
periodically in combating environmental stresses, e.g., 
confronting potentially hazardous anti-bacterial agents, 
such as antibiotics (Bennett, 2008). Useful genes are 
thought to be selected and persist that ultimately confer 
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better adaptability to microorganisms. Plasmid profil-
ing in pathogenic isolates of A. hydrophila from fishes 
with ulcers, had been done to investigate plasmid-
mediated virulence potential of the bacterium. Plas-
mid profiling, plasmid-mediated antibiotic resistance 
and pathogenesis in aeromonads have been investigated 
by several groups but further works are necessary to 
investigate the mode of transmission of virulence and 
drug-resistance genes in this bacterial group. This is 
imperative in heavily populated tropical countries like 
India, especially where sanitary requirements are not 
upto the standard.
Moreover, knowledge on how antibiotic resistance 
develops and is spread by mobile genetic elements is 
necessary for designing and developing prevention 
strategies intended to minimize the threat of bacte-
rial infections. Considering the great adaptive ability 
of these bacteria vis-a-vis the environmental stresses 
and increasing use of anti-bacterial agents in combating 
Aeromonas-associated pathogenesis, newer virulence 
genes may be acquired by these organisms. Therefore, 
a search and mapping for putative virulence genes of 
Aeromonas should be undertaken. 
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